321 related articles for article (PubMed ID: 19041000)
1. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM
Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000
[TBL] [Abstract][Full Text] [Related]
2. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma.
Yu XM; Lo CY; Lam AK; Leung P; Luk JM
Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194
[TBL] [Abstract][Full Text] [Related]
3. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma.
Mitsuhashi A; Suzuka K; Yamazawa K; Matsui H; Seki K; Sekiya S
Cancer; 2005 Feb; 103(4):724-30. PubMed ID: 15637689
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of vascular endothelial growth factor C in papillary thyroid carcinoma correlates with cervical lymph node metastases.
Yu XM; Lo CY; Chan WF; Lam KY; Leung P; Luk JM
Clin Cancer Res; 2005 Nov; 11(22):8063-9. PubMed ID: 16299237
[TBL] [Abstract][Full Text] [Related]
5. Serum vascular endothelial growth factor-C level in patients with primary nonsmall cell lung carcinoma: a possible diagnostic tool for lymph node metastasis.
Tamura M; Ohta Y
Cancer; 2003 Sep; 98(6):1217-22. PubMed ID: 12973845
[TBL] [Abstract][Full Text] [Related]
6. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group.
Werther K; Christensen IJ; Brünner N; Nielsen HJ
Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612
[TBL] [Abstract][Full Text] [Related]
7. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer.
Oehler MK; Caffier H
Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
Miyazaki T; Okada N; Ishibashi K; Ogata K; Ohsawa T; Ishiguro T; Nakada H; Yokoyama M; Matsuki M; Kato H; Kuwano H; Ishida H
Jpn J Clin Oncol; 2008 Dec; 38(12):839-43. PubMed ID: 18923001
[TBL] [Abstract][Full Text] [Related]
9. The combination assay with circulating vascular endothelial growth factor (VEGF)-C, matrix metalloproteinase-9, and VEGF for diagnosing lymph node metastasis in patients with non-small cell lung cancer.
Tamura M; Oda M; Matsumoto I; Tsunezuka Y; Kawakami K; Ohta Y; Watanabe G
Ann Surg Oncol; 2004 Oct; 11(10):928-33. PubMed ID: 15383417
[TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor is a predictor of invasion and metastasis in hepatocellular carcinoma.
Li XM; Tang ZY; Qin LX; Zhou J; Sun HC
J Exp Clin Cancer Res; 1999 Dec; 18(4):511-7. PubMed ID: 10746978
[TBL] [Abstract][Full Text] [Related]
11. Elevation of serum vascular endothelial growth factor in male patients with metastatic nasopharyngeal carcinoma.
Qian CN; Zhang CQ; Guo X; Hong MH; Cao SM; Mai WY; Min HQ; Zeng YX
Cancer; 2000 Jan; 88(2):255-61. PubMed ID: 10640954
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum vascular endothelial growth factor-C (VEGF-C) levels predict recurrence in patients with esophageal cancer.
Kimura H; Kato H; Tanaka N; Inose T; Faried A; Sohda M; Nakajima M; Fukai Y; Miyazaki T; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2008; 28(1A):165-9. PubMed ID: 18383841
[TBL] [Abstract][Full Text] [Related]
13. Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come.
Aref S; El Sherbiny M; Goda T; Fouda M; Al Askalany H; Abdalla D
Hematology; 2005 Apr; 10(2):131-4. PubMed ID: 16019458
[TBL] [Abstract][Full Text] [Related]
14. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
15. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
16. Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer.
Wang TB; Wang J; Wei XQ; Wei B; Dong WG
Asia Pac J Clin Oncol; 2012 Jun; 8(2):180-6. PubMed ID: 22524577
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC).
Krzystek-Korpacka M; Matusiewicz M; Diakowska D; Grabowski K; Blachut K; Banas T
Cancer Lett; 2007 May; 249(2):171-7. PubMed ID: 17011116
[TBL] [Abstract][Full Text] [Related]
18. Serum vascular endothelial growth factor-D levels correlate with cervical lymph node metastases in papillary thyroid carcinoma.
Lai CW; Chen KY; Hung CS; Kuo SW; Chang YJ; Lin MT; Chang KC; Wu MH
Growth Factors; 2011 Apr; 29(2-3):57-62. PubMed ID: 21319951
[TBL] [Abstract][Full Text] [Related]
19. [Relationship between serum VEGF level and VEGF, COX-2 and MVD expression in breast cancer tissues].
Li EX; Wu YY; Shi F; Wu Y; Guo JJ; Dong DF
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):522-5. PubMed ID: 18069633
[TBL] [Abstract][Full Text] [Related]
20. High preoperative serum vascular endothelial growth factor levels predict poor clinical outcome after curative resection of gastric cancer.
Vidal O; Metges JP; Elizalde I; ValentÃni M; Volant A; Molina R; Castells A; Pera M
Br J Surg; 2009 Dec; 96(12):1443-51. PubMed ID: 19918848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]